Use Hospira Inc. story concurrently with your other holdings to enhance returns of your portfolios and to back test it against optimization strategy that fits your risk preferences.
Solar cells are seen at the Ukishima Solar Power Plant in Kawasaki city, Kanagawa prefecture, south of Tokyo on August 25, 2011. (TOSHIFUMI KITAMURA/AFP/Getty Images) NEW YORK -- Solar panel manufacturers will have a hard time boosting revenues this ...
The Solar Fun Is Done For Now - Seeking Alpha
Overcapacity could drag on solar for some time - BusinessWeek
Story Momentum
This story from www.huffingtonpost.com contributed to next trading day price increase. The story delta to the next closing price was 4.20% . The story delta to the current price is 11.43% .
FiercePharma - May 16, 2012
Eloxatin managed to make the top 5 this time based on 2011, but 2012 may be another story. The drug goes off patent in August, and a slew of generics are already approved.
As per reports, it has been revealed that Hospira Inc. (HSP) has recalled one lot of Hydromorphone Hydrochloride Injection, as it contained more than desired opioid.
NASDAQ - May 15, 2012
(RTTNews.com) - Hospira Inc.(HSP) has initiated a nationwide voluntary recall of one lot of Hydromorphone Hydrochloride Injection 1 mg/ml, with the knowledge of the FDA, after it was found that the opioid analgesic injection contained more than the ...
Shares Owned by Institutions show percentage of the outstanding shares of stock issued by a company that are currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
USA 
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Summary
Fundamentals
Technicals
Performance
Valuation
Volatility
History
News
Management
Discussion
